31st week of 2020 patent applcation highlights part 27 |
Patent application number | Title | Published |
20200239440 | OPTICALLY ACTIVE PYRROLIDINE COMPOUND AND METHOD FOR PRODUCING SAME | 2020-07-30 |
20200239441 | KIF18A INHIBITORS | 2020-07-30 |
20200239442 | BIS(PENTAHYDROXYHEXYL)AMINO SUBSTITUTED 2-{[(3-AMINO-PYRAZIN-2-YL)FORMAMIDO]METHYL}-1H-1,3-BENZODIAZOL-3-IUM DERIVATIVES AS ENAC INHIBITORS FOR TREATING RESPIRATORY DISEASES | 2020-07-30 |
20200239443 | Preparation Method for Tyrosine Kinase Inhibitor and Intermediate Thereof | 2020-07-30 |
20200239444 | COMPOUNDS USEFUL FOR TREATING CANCER | 2020-07-30 |
20200239445 | 2,4-DIAMINO-6-ETHYLPYRIMIDINE DERIVATIVES WITH ANTIMALARIAL ACTIVITIES AGAINST PLASMODIUM FALCIPARUM | 2020-07-30 |
20200239446 | ANTIVIRAL COMPOUNDS | 2020-07-30 |
20200239448 | NR4A1 LIGANDS, PHARMACEUTICAL COMPOSITIONS, AND RELATED METHODS OF USE | 2020-07-30 |
20200239449 | CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE | 2020-07-30 |
20200239450 | CRYSTAL FORM OF ANDROGEN RECEPTOR ANTAGONIST MEDICATION, PREPARATION METHOD THEREFOR, AND USE | 2020-07-30 |
20200239451 | SUBSTITUTED PYRAZOLE-PYRIMIDINES, VARIANTS THEREOF, AND USES THEREFORE | 2020-07-30 |
20200239452 | IDO/TDO Inhibitor | 2020-07-30 |
20200239453 | PROCESS FOR PREPARING A COMPOUND USEFUL TO TREAT MYCOSES | 2020-07-30 |
20200239454 | SULFONYL SUBSTITUTED BICYCLIC COMPOUND WHICH ACTS AS ROR INHIBITOR | 2020-07-30 |
20200239455 | DANTROLENE PRODRUGS AND METHODS OF THEIR USE | 2020-07-30 |
20200239456 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-07-30 |
20200239457 | 5-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | 2020-07-30 |
20200239458 | INHIBITORS OF PROTEIN KINASES | 2020-07-30 |
20200239459 | INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE | 2020-07-30 |
20200239460 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | 2020-07-30 |
20200239461 | CHEMICAL PROCESS FOR MANUFACTURING MONOBACTAM ANTIBIOTIC AND INTERMEDIATES THEREOF | 2020-07-30 |
20200239462 | TRI-SUBSTITUTED IMIDAZOLES FOR THE INHIBITION OF TGF BETA AND METHODS OF TREATMENT | 2020-07-30 |
20200239463 | INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF | 2020-07-30 |
20200239464 | CYCLIC COMPOUNDS AS IMMUNOMODULATING AGENTS | 2020-07-30 |
20200239465 | FUSED RING DERIVATIVE AS A2A RECEPTOR INHIBITOR | 2020-07-30 |
20200239466 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | 2020-07-30 |
20200239467 | CHEMICAL COMPOUNDS | 2020-07-30 |
20200239468 | Selective Estrogen Receptor Down-Regulators | 2020-07-30 |
20200239469 | FORMS OF METHYL {4,6-DIAMINO-2-[1 (2-FLUOROBENZYL)-1H-PYRAZOLO[3-4-B]PYRIDINO-3-YL]PYRIMIDINO-5-YL}METHYL CARBAMATE | 2020-07-30 |
20200239470 | Substituted Pyrimidine Compound for Treating Cancer | 2020-07-30 |
20200239471 | SYNTHESIS OF COELENTERAZINE | 2020-07-30 |
20200239472 | TARGETED THERAPEUTICS | 2020-07-30 |
20200239473 | NEW DERIVATIVES OF LICOFELONE | 2020-07-30 |
20200239474 | PYRROLO-PYRIMIDINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME COMPOUND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE | 2020-07-30 |
20200239475 | CELL IMPERMEABLE COELENTERAZINE ANALOGUES | 2020-07-30 |
20200239476 | GPR35 MODULATORS | 2020-07-30 |
20200239477 | METHOD FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(PYRIDIN-2-YL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZ- EPIN-4-YL]-PROPIONIC ACID METHYL ESTER, AND COMPOUNDS USEFUL IN SAID METHOD | 2020-07-30 |
20200239478 | 2-PHENYL-3,4-DIHYDROPYRROLO[2,1 -F] [1,2,4]TRIAZINONE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS AND USES THEREOF | 2020-07-30 |
20200239479 | Pyrazolopyrimidine Modulators of RAS GTPase | 2020-07-30 |
20200239480 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | 2020-07-30 |
20200239481 | Synthetic Process and Novel Intermediates | 2020-07-30 |
20200239482 | PYRAZOLOPYRIMIDINE DERIVATIVES | 2020-07-30 |
20200239483 | PROTEIN KINASE B INHIBITORS | 2020-07-30 |
20200239484 | METHOD FOR PREPARING PYRROLO[3,2,-D]PYRIMIDINE COMPOUND, AND INTERMEDIATES THEREOF | 2020-07-30 |
20200239485 | THIOGLYCOLURIL COMPOUND, AND METHOD FOR PRODUCING SAME | 2020-07-30 |
20200239486 | PYRIMIDINE-BASED COMPOUNDS FOR THE TREATMENT OF CANCER | 2020-07-30 |
20200239487 | 1,5-DISUBSTITUTED 1,2,3-TRIAZOLES ARE INHIBITORS OF RAC/CDC42 GTPASES | 2020-07-30 |
20200239488 | SHMT Inhibitors | 2020-07-30 |
20200239489 | Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)- pyrrole-2,5-dione | 2020-07-30 |
20200239490 | PYRIDINE DERIVATIVES | 2020-07-30 |
20200239491 | MEROCYANINE-BASED COMPOUND AND BIOMOLECULAR LABELING DYE, KIT AND CONTRAST AGENT COMPOSITION COMPRISING SAME | 2020-07-30 |
20200239492 | Continuous Process for Cycloaddition Reactions | 2020-07-30 |
20200239493 | SUBSTITUTED DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 2020-07-30 |
20200239494 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | 2020-07-30 |
20200239495 | NOVEL 2-CARBOXYPENAM COMPOUND OR SALT THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING NOVEL 2-CARBOXYPENAM COMPOUND OR SALT THEREOF, AND APPLICATIONS THEREOF | 2020-07-30 |
20200239496 | Hydrocarbon-Soluble Halogen and Thiolate/Magnesium Exchange Reagents | 2020-07-30 |
20200239497 | SOLID FORMS OF SUBSTITUTED BENZOXABOROLE AND COMPOSITIONS THEREOF | 2020-07-30 |
20200239498 | MONOALKYL TIN TRIALKOXIDES AND/OR MONOALKYL TIN TRIAMIDES WITH PARTICULATE CONTAMINATION AND CORRESPONDING METHODS | 2020-07-30 |
20200239499 | ORGANIC-INORGANIC PEROVSKITE MATERIALS AND METHODS OF MAKING THE SAME | 2020-07-30 |
20200239500 | Compositions and Methods for Synthesis of Phosphorylated Molecules | 2020-07-30 |
20200239501 | PHOSPHOROUS CONTAINING ANTIWEAR ADDITIVES | 2020-07-30 |
20200239502 | DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER | 2020-07-30 |
20200239503 | PHOTOACTIVATABLE CANCER PRODRUG | 2020-07-30 |
20200239504 | METAL COMPLEXES COMPRISING ANILINE TYPE LIGANDS | 2020-07-30 |
20200239505 | BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES | 2020-07-30 |
20200239506 | BIFLAVONE-IRON COMPLEX, PREPARATION METHOD AND APPLICATION THEREOF | 2020-07-30 |
20200239507 | BIFLAVONE-COBALT COMPLEX, PREPARATION METHOD AND APPLICATION THEREOF | 2020-07-30 |
20200239508 | Extraction of Lignin From Lignocellulosic Waste Material Using Pyridinium Ionic Liquid | 2020-07-30 |
20200239509 | TRITERPENE SAPONIN ANALOGUES | 2020-07-30 |
20200239510 | CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR | 2020-07-30 |
20200239511 | LACTOBIONIC ACID PRODUCTION METHODS AND PRODUCTS | 2020-07-30 |
20200239512 | METHODS OF PREVENTING OR TREATING ATHEROSCLEROSIS WITH INHIBITORS OF SPECIFIC ISOENZYMES OF HUMAN NEURAMINIDASE | 2020-07-30 |
20200239513 | LONG-ACTING PRODRUGS OF ENTECAVIR, PREPARING METHODS AND USES THEREOF | 2020-07-30 |
20200239514 | 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-D]PYRIMIDINE-2, 7-DIONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | 2020-07-30 |
20200239515 | METHODS AND INTERMEDIATES FOR THE PREPARATION BILE ACID DERIVATIVES | 2020-07-30 |
20200239516 | Multicyclic Peptides and Methods for Their Preparation | 2020-07-30 |
20200239517 | Method of Storing a Separation Matrix | 2020-07-30 |
20200239518 | MANUFACTURING OPTIMIZATION OF GL-2045, A MULTIMERIZING STRADOMER | 2020-07-30 |
20200239519 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | 2020-07-30 |
20200239520 | ANTICANCER PEPTIDES AND USES THEREOF | 2020-07-30 |
20200239521 | NOXA-DERIVED, CELL DEATH-INDUCING PEPTIDE eMTD | 2020-07-30 |
20200239522 | Optimized Peptides for Targeting Human Nerves and Their Use in Image Guided Surgery, Diagnostics and Therapeutic Delivery | 2020-07-30 |
20200239523 | NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS | 2020-07-30 |
20200239524 | DE NOVO DESIGN OF PROTEIN SWITCHES | 2020-07-30 |
20200239525 | MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO | 2020-07-30 |
20200239526 | CHIMERIC M. HYORHINIS POLYPROTEIN FOR VACCINES AND DIAGNOSTICS | 2020-07-30 |
20200239527 | COMPOSITIONS COMPRISING A CHIMERIC BACTERIAL SURFACE LAYER PROTEIN AND METHODS OF USE THEREOF | 2020-07-30 |
20200239528 | NON-NEURONAL SNARE-CLEAVING BOTULINUM NEUROTOXINS | 2020-07-30 |
20200239529 | NANOSTRUCTURED PROTEINS AND USES THEREOF | 2020-07-30 |
20200239530 | COMPOUNDS AND METHODS OF MODULATING PROTEIN DEGRADATION | 2020-07-30 |
20200239531 | CONJUGATED KNOTTIN MINI-PROTEINS CONTAINING NON-NATURAL AMINO ACIDS | 2020-07-30 |
20200239532 | RECOMBINANT FUSION PROTEIN OF BAF57 AND USES THEREOF | 2020-07-30 |
20200239533 | RAS INHIBITORY PEPTIDES AND USES THEREOF | 2020-07-30 |
20200239534 | BINDING DOMAINS DIRECTED AGAINST GPCR:G PROTEIN COMPLEXES AND USES DERIVED THEREOF | 2020-07-30 |
20200239535 | Cancer Treatment | 2020-07-30 |
20200239536 | CYCLIC GALANIN-ANALOGS AND USES THEREOF | 2020-07-30 |
20200239537 | APELIN PEPTIDES AND USES THEREOF | 2020-07-30 |
20200239538 | GLUCOSE TRANSPORTER INHIBITOR-MODIFIED INSULIN FOR GLUCOSE-RESPONSIVE INSULIN DELIVERY | 2020-07-30 |
20200239539 | CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S) | 2020-07-30 |
20200239540 | CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S) | 2020-07-30 |